Biomarker news, Faecal biomarker for the diagnosis of Parkinson’s disease

Faecal chymotrypsin levels are decreased in Parkinson's disease patients and this could be used as a biomarker

 Parkinson's disease genes and risk factors  Tweet

Related articles

• DaTscan allows doctors to differentiate Parkinson's from other movement disorders (news-medical.net)
• Parkinson's disease breakthrough with stem cell research (news-medical.net)